C07C 211/47
Toluidines
Official title: Toluidines; Homologues thereof
C07C211/47 (Toluidines) appears on 19 US grants and 18 published applications in this corpus.
Search patents in C07C- Granted patents
- 19
- Published applications
- 18
- Assignees
- 10
- Inventors
- 43
- Latest grant
- 7 Feb 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 1 |
| 2003 | 0 | 0 |
| 2004 | 1 | 1 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 1 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 1 |
| 2011 | 1 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 2 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 2 |
| 2021 | 0 | 2 |
| 2022 | 1 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Syntheses of N-heterocyclic carbenes and intermediates therefor7 Feb 2023US 11,572,348 B2Umicore AG & Co. KG
- Method for converting N,N-dialkylamide compound into ester compound using complex of fourth-period transition metal as catalyst5 Jul 2022US 11,377,415 B2Osaka University
- Syntheses of N-heterocyclic carbenes and intermediates therefor1 Sep 2020US 10,759,763 B2Umicore AG & Co. KG
- Syntheses of N-heterocyclic carbenes and intermediates therefor13 Feb 2018US 9,890,125 B2University Court of the University of St Andrews
- Agricultural/horticultural insecticide and method for using the same11 Aug 2015US 9,101,135 B2Mitsui Chemicals, Inc.
- Conversion of a hydrocarbon feedstock derived from oxygen-rich biomass into aromatic isocyanates23 Jul 2026US 2026/0209166 A1Ifp Energies Nouvelles
- Methods of using ehmt2 inhibitors in treating or preventing blood disorders6 Jun 2024US 2024/0180880 A1Epizyme, Inc.
- Syntheses of n-heterocyclic carbenes and intermediates therefor14 Oct 2021US 2021/0317088 A9Umicore AG & Co. KG
- Methods of using ehmt2 inhibitors in treating or preventing blood disorders26 Aug 2021US 2021/0260040 A1
- Method for converting n,n-dialkylamide compound into ester compound using complex of fourth-period transition metal as catalyst24 Dec 2020US 2020/0399200 A1Osaka University
Most cited
By later US patents
- Arylphenyl-substituted cyclic keto-enols85US 6,417,370 B1Bayer Aktiengesellschaft · 2002
- Fullerene derivatives32US 6,380,434 B12002
- Arylphenyl-substituted cyclic keto-enols19US 8,058,210 B2Bayer CropScience AG · 2011
- Arylphenyl-substituted cyclic ketoenols13US 6,716,832 B2Bayer Aktiengesellschaft · 2004
- Polyorganofullerenes9US 6,020,523 A2000